International Journal of Clinical Rheumatology : Citations & Metrics Report
Articles published in International Journal of Clinical Rheumatology have been cited by esteemed scholars and scientists all around the world.
International Journal of Clinical Rheumatology has got h-index 36, which means every article in International Journal of Clinical Rheumatology has got 36 average citations.
Following are the list of articles that have cited the articles published in International Journal of Clinical Rheumatology.
2024
2023
2022
2021
2020
2019
2018
Total published articles
74
103
59
49
39
47
58
Citations received as per Google Scholar, other indexing platforms and portals
60
103
582
651
520
511
461
Journal total citations count
6123
Journal impact factor
11.84
Journal 5 years impact factor
10.98
Journal cite score
11.91
Journal h-index
36
Journal h-index since 2019
27
Journal Impact Factor 2020 formula
IF= Citations(y)/{Publications(y-1)+ Publications(y-2)}
Y= Year
Citescorey = Citationsy + Citationsy-1 + Citationsy-2 + Citations y-3 / Published articlesy + Published articlesy-1 + Published articlesy-2 + Published articles y-3
Lemmey, A. B., Marcora, S. M., Chester, K., Wilson, S., Casanova, F., & Maddison, P. J. Efficacy of progressive resistance training for patients with rheumatoid arthritis and recommendations regarding its prescription. International Journal of Clinical Rheumatology, 6(2), 189.(2011) View at Publisher|View at Google Scholar|View at Indexing
Lemmey, A. B., Marcora, S. M., Chester, K., Wilson, S., Casanova, F., & Maddison, P. J. Efficacy of progressive resistance training for patients with rheumatoid arthritis and recommendations regarding its prescription. International Journal of Clinical Rheumatology, 6(2), 189.(2011) View at Publisher|View at Google Scholar|View at Indexing
Lemmey, A. B., Marcora, S. M., Chester, K., Wilson, S., Casanova, F., & Maddison, P. J. Efficacy of progressive resistance training for patients with rheumatoid arthritis and recommendations regarding its prescription. International Journal of Clinical Rheumatology, 6(2), 189.(2011) View at Publisher|View at Google Scholar|View at Indexing
Lemmey, A. B., Marcora, S. M., Chester, K., Wilson, S., Casanova, F., & Maddison, P. J. Efficacy of progressive resistance training for patients with rheumatoid arthritis and recommendations regarding its prescription. International Journal of Clinical Rheumatology, 6(2), 189.(2011) View at Publisher|View at Google Scholar|View at Indexing
Lemmey, A. B., Marcora, S. M., Chester, K., Wilson, S., Casanova, F., & Maddison, P. J. Efficacy of progressive resistance training for patients with rheumatoid arthritis and recommendations regarding its prescription. International Journal of Clinical Rheumatology, 6(2), 189.(2011) View at Publisher|View at Google Scholar|View at Indexing
Lemmey, A. B., Marcora, S. M., Chester, K., Wilson, S., Casanova, F., & Maddison, P. J. Efficacy of progressive resistance training for patients with rheumatoid arthritis and recommendations regarding its prescription. International Journal of Clinical Rheumatology, 6(2), 189.(2011) View at Publisher|View at Google Scholar|View at Indexing
Lemmey, A. B., Marcora, S. M., Chester, K., Wilson, S., Casanova, F., & Maddison, P. J. Efficacy of progressive resistance training for patients with rheumatoid arthritis and recommendations regarding its prescription. International Journal of Clinical Rheumatology, 6(2), 189.(2011) View at Publisher|View at Google Scholar|View at Indexing
Taylor-Gjevre, R., Gjevre, J. A., Skomro, R., & Nair, B. V. Assessment of sleep health in patients with rheumatic disease. International Journal of Clinical Rheumatology, 6(2), 207. (2011) View at Publisher|View at Google Scholar|View at Indexing
Taylor-Gjevre, R., Gjevre, J. A., Skomro, R., & Nair, B. V. Assessment of sleep health in patients with rheumatic disease. International Journal of Clinical Rheumatology, 6(2), 207. (2011) View at Publisher|View at Google Scholar|View at Indexing
Taylor-Gjevre, R., Gjevre, J. A., Skomro, R., & Nair, B. V. Assessment of sleep health in patients with rheumatic disease. International Journal of Clinical Rheumatology, 6(2), 207. (2011) View at Publisher|View at Google Scholar|View at Indexing
Taylor-Gjevre, R., Gjevre, J. A., Skomro, R., & Nair, B. V. Assessment of sleep health in patients with rheumatic disease. International Journal of Clinical Rheumatology, 6(2), 207. (2011) View at Publisher|View at Google Scholar|View at Indexing
Taylor-Gjevre, R., Gjevre, J. A., Skomro, R., & Nair, B. V. Assessment of sleep health in patients with rheumatic disease. International Journal of Clinical Rheumatology, 6(2), 207. (2011) View at Publisher|View at Google Scholar|View at Indexing
Taylor-Gjevre, R., Gjevre, J. A., Skomro, R., & Nair, B. V. Assessment of sleep health in patients with rheumatic disease. International Journal of Clinical Rheumatology, 6(2), 207. (2011) View at Publisher|View at Google Scholar|View at Indexing
Taylor-Gjevre, R., Gjevre, J. A., Skomro, R., & Nair, B. V. Assessment of sleep health in patients with rheumatic disease. International Journal of Clinical Rheumatology, 6(2), 207. (2011) View at Publisher|View at Google Scholar|View at Indexing
Chighizola, C., Ong, V. H., & Denton, C. P. Cyclophosphamide as disease-modifying therapy for scleroderma: pros and cons. International Journal of Clinical Rheumatology, 6(2), 219.(2011) View at Publisher|View at Google Scholar|View at Indexing
Chighizola, C., Ong, V. H., & Denton, C. P. Cyclophosphamide as disease-modifying therapy for scleroderma: pros and cons. International Journal of Clinical Rheumatology, 6(2), 219.(2011) View at Publisher|View at Google Scholar|View at Indexing
Chighizola, C., Ong, V. H., & Denton, C. P. Cyclophosphamide as disease-modifying therapy for scleroderma: pros and cons. International Journal of Clinical Rheumatology, 6(2), 219.(2011) View at Publisher|View at Google Scholar|View at Indexing
Chighizola, C., Ong, V. H., & Denton, C. P. Cyclophosphamide as disease-modifying therapy for scleroderma: pros and cons. International Journal of Clinical Rheumatology, 6(2), 219.(2011) View at Publisher|View at Google Scholar|View at Indexing
Chighizola, C., Ong, V. H., & Denton, C. P. Cyclophosphamide as disease-modifying therapy for scleroderma: pros and cons. International Journal of Clinical Rheumatology, 6(2), 219.(2011) View at Publisher|View at Google Scholar|View at Indexing
Chighizola, C., Ong, V. H., & Denton, C. P. Cyclophosphamide as disease-modifying therapy for scleroderma: pros and cons. International Journal of Clinical Rheumatology, 6(2), 219.(2011) View at Publisher|View at Google Scholar|View at Indexing
Chighizola, C., Ong, V. H., & Denton, C. P. Cyclophosphamide as disease-modifying therapy for scleroderma: pros and cons. International Journal of Clinical Rheumatology, 6(2), 219.(2011) View at Publisher|View at Google Scholar|View at Indexing
Sokka, T. Influence of gender on the symptoms and severity of rheumatoid arthritis: do women suffer more?. International Journal of Clinical Rheumatology, 4(3), 245.(2009) View at Publisher|View at Google Scholar|View at Indexing
Levy, S., Pilcher, J., Heron, C., & Kiely, P. Intra-articular infliximab in DMARD-resistant knee monoarthritis: clinical and ultrasound responses. International Journal of Clinical Rheumatology, 6(2), 231. (2011) View at Publisher|View at Google Scholar|View at Indexing
Levy, S., Pilcher, J., Heron, C., & Kiely, P. Intra-articular infliximab in DMARD-resistant knee monoarthritis: clinical and ultrasound responses. International Journal of Clinical Rheumatology, 6(2), 231. (2011) View at Publisher|View at Google Scholar|View at Indexing
Clarke, L. L., Jessop, D. S., Hunt, L. P., Straub, R. H., Perry, M. G., & Kirwan, J. R.Alleviation of morning joint stiffness by low-dose prednisone in rheumatoid arthritis is associated with circadian changes in IL-6 and cortisol. International Journal of Clinical Rheumatology, 6(2), 241. (2011) View at Publisher|View at Google Scholar|View at Indexing
Clarke, L. L., Jessop, D. S., Hunt, L. P., Straub, R. H., Perry, M. G., & Kirwan, J. R.Alleviation of morning joint stiffness by low-dose prednisone in rheumatoid arthritis is associated with circadian changes in IL-6 and cortisol. International Journal of Clinical Rheumatology, 6(2), 241. (2011) View at Publisher|View at Google Scholar|View at Indexing
Clarke, L. L., Jessop, D. S., Hunt, L. P., Straub, R. H., Perry, M. G., & Kirwan, J. R.Alleviation of morning joint stiffness by low-dose prednisone in rheumatoid arthritis is associated with circadian changes in IL-6 and cortisol. International Journal of Clinical Rheumatology, 6(2), 241. (2011) View at Publisher|View at Google Scholar|View at Indexing
Clarke, L. L., Jessop, D. S., Hunt, L. P., Straub, R. H., Perry, M. G., & Kirwan, J. R.Alleviation of morning joint stiffness by low-dose prednisone in rheumatoid arthritis is associated with circadian changes in IL-6 and cortisol. International Journal of Clinical Rheumatology, 6(2), 241. (2011) View at Publisher|View at Google Scholar|View at Indexing
Clarke, L. L., Jessop, D. S., Hunt, L. P., Straub, R. H., Perry, M. G., & Kirwan, J. R.Alleviation of morning joint stiffness by low-dose prednisone in rheumatoid arthritis is associated with circadian changes in IL-6 and cortisol. International Journal of Clinical Rheumatology, 6(2), 241. (2011) View at Publisher|View at Google Scholar|View at Indexing
Clarke, L. L., Jessop, D. S., Hunt, L. P., Straub, R. H., Perry, M. G., & Kirwan, J. R.Alleviation of morning joint stiffness by low-dose prednisone in rheumatoid arthritis is associated with circadian changes in IL-6 and cortisol. International Journal of Clinical Rheumatology, 6(2), 241. (2011) View at Publisher|View at Google Scholar|View at Indexing
Clarke, L. L., Jessop, D. S., Hunt, L. P., Straub, R. H., Perry, M. G., & Kirwan, J. R.Alleviation of morning joint stiffness by low-dose prednisone in rheumatoid arthritis is associated with circadian changes in IL-6 and cortisol. International Journal of Clinical Rheumatology, 6(2), 241. (2011) View at Publisher|View at Google Scholar|View at Indexing
Clarke, L. L., Jessop, D. S., Hunt, L. P., Straub, R. H., Perry, M. G., & Kirwan, J. R.Alleviation of morning joint stiffness by low-dose prednisone in rheumatoid arthritis is associated with circadian changes in IL-6 and cortisol. International Journal of Clinical Rheumatology, 6(2), 241. (2011) View at Publisher|View at Google Scholar|View at Indexing
Clarke, L. L., Jessop, D. S., Hunt, L. P., Straub, R. H., Perry, M. G., & Kirwan, J. R.Alleviation of morning joint stiffness by low-dose prednisone in rheumatoid arthritis is associated with circadian changes in IL-6 and cortisol. International Journal of Clinical Rheumatology, 6(2), 241. (2011) View at Publisher|View at Google Scholar|View at Indexing
Clarke, L. L., Jessop, D. S., Hunt, L. P., Straub, R. H., Perry, M. G., & Kirwan, J. R.Alleviation of morning joint stiffness by low-dose prednisone in rheumatoid arthritis is associated with circadian changes in IL-6 and cortisol. International Journal of Clinical Rheumatology, 6(2), 241. (2011) View at Publisher|View at Google Scholar|View at Indexing
Clarke, L. L., Jessop, D. S., Hunt, L. P., Straub, R. H., Perry, M. G., & Kirwan, J. R.Alleviation of morning joint stiffness by low-dose prednisone in rheumatoid arthritis is associated with circadian changes in IL-6 and cortisol. International Journal of Clinical Rheumatology, 6(2), 241. (2011) View at Publisher|View at Google Scholar|View at Indexing
Clarke, L. L., Jessop, D. S., Hunt, L. P., Straub, R. H., Perry, M. G., & Kirwan, J. R.Alleviation of morning joint stiffness by low-dose prednisone in rheumatoid arthritis is associated with circadian changes in IL-6 and cortisol. International Journal of Clinical Rheumatology, 6(2), 241. (2011) View at Publisher|View at Google Scholar|View at Indexing
Clarke, L. L., Jessop, D. S., Hunt, L. P., Straub, R. H., Perry, M. G., & Kirwan, J. R.Alleviation of morning joint stiffness by low-dose prednisone in rheumatoid arthritis is associated with circadian changes in IL-6 and cortisol. International Journal of Clinical Rheumatology, 6(2), 241. (2011) View at Publisher|View at Google Scholar|View at Indexing
Clarke, L. L., Jessop, D. S., Hunt, L. P., Straub, R. H., Perry, M. G., & Kirwan, J. R.Alleviation of morning joint stiffness by low-dose prednisone in rheumatoid arthritis is associated with circadian changes in IL-6 and cortisol. International Journal of Clinical Rheumatology, 6(2), 241. (2011) View at Publisher|View at Google Scholar|View at Indexing
Clarke, L. L., Jessop, D. S., Hunt, L. P., Straub, R. H., Perry, M. G., & Kirwan, J. R.Alleviation of morning joint stiffness by low-dose prednisone in rheumatoid arthritis is associated with circadian changes in IL-6 and cortisol. International Journal of Clinical Rheumatology, 6(2), 241. (2011) View at Publisher|View at Google Scholar|View at Indexing
Clarke, L. L., Jessop, D. S., Hunt, L. P., Straub, R. H., Perry, M. G., & Kirwan, J. R.Alleviation of morning joint stiffness by low-dose prednisone in rheumatoid arthritis is associated with circadian changes in IL-6 and cortisol. International Journal of Clinical Rheumatology, 6(2), 241. (2011) View at Publisher|View at Google Scholar|View at Indexing
Clarke, L. L., Jessop, D. S., Hunt, L. P., Straub, R. H., Perry, M. G., & Kirwan, J. R.Alleviation of morning joint stiffness by low-dose prednisone in rheumatoid arthritis is associated with circadian changes in IL-6 and cortisol. International Journal of Clinical Rheumatology, 6(2), 241. (2011) View at Publisher|View at Google Scholar|View at Indexing
Clarke, L. L., Jessop, D. S., Hunt, L. P., Straub, R. H., Perry, M. G., & Kirwan, J. R.Alleviation of morning joint stiffness by low-dose prednisone in rheumatoid arthritis is associated with circadian changes in IL-6 and cortisol. International Journal of Clinical Rheumatology, 6(2), 241. (2011) View at Publisher|View at Google Scholar|View at Indexing
Clarke, L. L., Jessop, D. S., Hunt, L. P., Straub, R. H., Perry, M. G., & Kirwan, J. R.Alleviation of morning joint stiffness by low-dose prednisone in rheumatoid arthritis is associated with circadian changes in IL-6 and cortisol. International Journal of Clinical Rheumatology, 6(2), 241. (2011) View at Publisher|View at Google Scholar|View at Indexing
Clarke, L. L., Jessop, D. S., Hunt, L. P., Straub, R. H., Perry, M. G., & Kirwan, J. R.Alleviation of morning joint stiffness by low-dose prednisone in rheumatoid arthritis is associated with circadian changes in IL-6 and cortisol. International Journal of Clinical Rheumatology, 6(2), 241. (2011) View at Publisher|View at Google Scholar|View at Indexing
Clarke, L. L., Jessop, D. S., Hunt, L. P., Straub, R. H., Perry, M. G., & Kirwan, J. R.Alleviation of morning joint stiffness by low-dose prednisone in rheumatoid arthritis is associated with circadian changes in IL-6 and cortisol. International Journal of Clinical Rheumatology, 6(2), 241. (2011) View at Publisher|View at Google Scholar|View at Indexing
Clarke, L. L., Jessop, D. S., Hunt, L. P., Straub, R. H., Perry, M. G., & Kirwan, J. R.Alleviation of morning joint stiffness by low-dose prednisone in rheumatoid arthritis is associated with circadian changes in IL-6 and cortisol. International Journal of Clinical Rheumatology, 6(2), 241. (2011) View at Publisher|View at Google Scholar|View at Indexing
Mease, P. J. Certolizumab pegol for rheumatoid arthritis: Effective in combination with methotrexate or as monotherapy. International Journal of Clinical Rheumatology, 4(3), 253. (2009) View at Publisher|View at Google Scholar|View at Indexing
Mease, P. J. Certolizumab pegol for rheumatoid arthritis: Effective in combination with methotrexate or as monotherapy. International Journal of Clinical Rheumatology, 4(3), 253. (2009) View at Publisher|View at Google Scholar|View at Indexing
Mease, P. J. Certolizumab pegol for rheumatoid arthritis: Effective in combination with methotrexate or as monotherapy. International Journal of Clinical Rheumatology, 4(3), 253. (2009) View at Publisher|View at Google Scholar|View at Indexing
AlarcóóN, G. S.Risk factors for thrombotic events in patients with systemic lupus erythematosus from different ethnic groups. International Journal of Clinical Rheumatology, 4(3), 267. (2009) View at Publisher|View at Google Scholar|View at Indexing
